These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16635495)

  • 1. Cognitive changes in early MS: a call for a common framework.
    Achiron A; Barak Y
    J Neurol Sci; 2006 Jun; 245(1-2):47-51. PubMed ID: 16635495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.
    Amato MP; Zipoli V; Portaccio E
    J Neurol Sci; 2006 Jun; 245(1-2):41-6. PubMed ID: 16643953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cognitive burden of multiple sclerosis in children.
    Banwell BL; Anderson PE
    Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study.
    Jønsson A; Andresen J; Storr L; Tscherning T; Soelberg Sørensen P; Ravnborg M
    J Neurol Sci; 2006 Jun; 245(1-2):77-85. PubMed ID: 16647089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cognitive dysfunction in multiple sclerosis.
    Sartori E; Edan G
    J Neurol Sci; 2006 Jun; 245(1-2):169-75. PubMed ID: 16678209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and rehabilitation of cognitive impairment in multiple sclerosis.
    Messinis L; Kosmidis MH; Lyros E; Papathanasopoulos P
    Int Rev Psychiatry; 2010; 22(1):22-34. PubMed ID: 20233112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cognitive impairment].
    Reuter F; Audoin B; Rico A; Malikova I; Ranjeva JP; Pelletier J
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S113-22. PubMed ID: 19361675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and neurophysiological correlates in MS.
    Magnano I; Aiello I; Piras MR
    J Neurol Sci; 2006 Jun; 245(1-2):117-22. PubMed ID: 16697015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting neuropsychological abnormalities in multiple sclerosis.
    Benedict RH; Zivadinov R
    J Neurol Sci; 2006 Jun; 245(1-2):67-72. PubMed ID: 16626751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis.
    Portaccio E; Goretti B; Lori S; Zipoli V; Centorrino S; Ghezzi A; Patti F; Bianchi V; Comi G; Trojano M; Amato MP;
    Mult Scler; 2009 May; 15(5):620-6. PubMed ID: 19318511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis.
    Porcel J; Montalban X
    J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamic atrophy and cognition in multiple sclerosis.
    Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
    Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.